港股异动 | 创新药概念股上涨，药明巨诺-B涨近12%_老虎社区_美港股上老虎

港股异动 | 创新药概念股上涨，药明巨诺-B涨近12%

智通财经2025-09-03

9月3日，创新药概念股盘中上涨，药明巨诺-B涨近12%，和铂医药-B、四环医药涨超8%，恒瑞医药涨近7%，联邦制药、药明合联涨超5%，石药集团涨超4%。消息面上，近期，外资密集举牌中国创新药企。根据香港联交所披露文件，8月29日，新加坡政府投资公司(GIC)增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2564335498?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","is_english":false,"pubTime":"2025-09-03 14:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564335498","market":"fut","top_or_hot":-1,"title":"港股异动 | 创新药概念股上涨，药明巨诺-B涨近12%","media":"智通财经","content":"<div>\n<p>9月3日，创新药概念股盘中上涨，药明巨诺-B涨近12%，和铂医药-B、四环医药涨超8%，恒瑞医药涨近7%，联邦制药、药明合联涨超5%，石药集团涨超4%。消息面上，近期，外资密集举牌中国创新药企。根据香港联交所披露文件，8月29日，新加坡政府投资公司(GIC)增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1340908.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 创新药概念股上涨，药明巨诺-B涨近12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 创新药概念股上涨，药明巨诺-B涨近12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-03 14:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1340908.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月3日，创新药概念股盘中上涨，药明巨诺-B涨近12%，和铂医药-B、四环医药涨超8%，恒瑞医药涨近7%，联邦制药、药明合联涨超5%，石药集团涨超4%。消息面上，近期，外资密集举牌中国创新药企。根据香港联交所披露文件，8月29日，新加坡政府投资公司(GIC)增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1340908.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0359201885.HKD","symbol_name":"BGF CHINA \"A2\" (HKD) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1340908.html","article_id":"2564335498","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564335498","pubTimestamp":1756879552,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"9月3日，创新药概念股盘中上涨，$药明巨诺-B$涨近12%，$和铂医药-B$、$四环医药$涨超8%，$恒瑞医药$涨近7%，$联邦制药$、$药明合联$涨超5%，$石药集团$涨超4%。消息面上，近期，外资密集举牌中国创新药企。根据香港联交所披露文件，8月29日，新加坡政府投资公司增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,397.7万股股份，好仓比例由1.62%升至6.37%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","BK1600":"工业大麻","BK1141":"生命科学工具和服务","BK1583":"高瓴概念","BK4614":"Manus概念股","BK1515":"抗疫概念","BK1161":"生物科技","LU0359201612.USD":"贝莱德中国基金A2","BK1574":"生物医药B类股","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK1593":"医美概念股","SG9999014674.SGD":"Nikko AM All China Equity A SGD","BK1191":"制药","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","02126":"药明巨诺-B"},"translate_title":"Changes in Hong Kong stocks | Innovative drugs continue recent gains, foreign capital intensive placards, Chinese innovative pharmaceutical companies and institutions are optimistic about the return of core asset value in the second half of the year","themeId":"38aecbed13f95ea9fcb945ec0f15221c","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/a4ad2bf4f47d6651a4f813792643154d","symbols_score_info":{"02126":1.1},"content_text":"9月3日，创新药概念股盘中上涨，药明巨诺-B涨近12%，和铂医药-B、四环医药涨超8%，恒瑞医药涨近7%，联邦制药、药明合联涨超5%，石药集团涨超4%。消息面上，近期，外资密集举牌中国创新药企。根据香港联交所披露文件，8月29日，新加坡政府投资公司(GIC)增持和铂医药4022.2万股普通股股份，每股均价12.7133港元，价值约5.11亿港元。增持后，新加坡政府投资公司最新持股数目为5,397.7万股股份，好仓比例由1.62%升至6.37%。此前8月18日，GIC用6.35亿港元买入基石药业8040万股，持股升至5.49%；8月26日，贝莱德举牌三生制药，持股比例达5.1%。值得一提的是，今年来，国产创新药BD高速增长。据华泰证券，年初至今，国产创新药已达成对外授权83项，涉及总金额845.31亿美元、首付款43.21亿美元。国金证券指出，展望下周，2025年世界肺癌大会（WCLC）将于9月6日-9日举行，本次大会，中国学者共有35项口头报告，国产新药临床数据披露值得期待。中邮证券则表示，看好下半年核心资产的价值回归。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}